drugset / Trial / NCT00763529
Elocon vs Fluticasone in Localized Psoriasis (P03197)
RandomizedParallel-groupOpen-labelTreatment
Summary
This is an open-label, randomized, parallel-group clinical study. The primary objective is to assess the difference in response rate between mometasone furoate cream 0.1% (once daily) vs fluticasone propionate cream 0.05% (twice daily) by the end of Day 4 and Day 8 in the management of Indian patients with localized psoriasis.
Timeline
- Start
- 2003-01-01
- Primary completion
- 2005-01-01
- Completion
- 2005-01-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Fluticasone | Other / unclassified | 0.05 % | Topical |
| Subject | Mometasone | Other / unclassified | 0.1 % | Topical |